Table 1 Sociodemographic and laboratory information of ESLD and Chronic HBV patients
HCC n/N* (%) | Cirrhosis n/N* (%) | Chronic HBV n/N* (%) | |
|---|---|---|---|
Sociodemographic information | |||
Sex | |||
Men | 106/139 (76.3) | 150/214 (70.1) | 125/218 (57.3) |
Women | 33/139 (23.7) | 64/214 (29.9) | 92/218 (42.2) |
Age at diagnosis, median (IQR) | |||
Overall | 44 (36–54) | 46 (37–46) | 35 (28–44) |
HBV | 43 (36–48) | 42 (34–50) | – |
HCV | 53 (47–65) | 49 (40.5–59.5) | – |
ALD | 42 (39–50) | 51 (44–60) | – |
Monthly household income in Ghana cedis, (GHS) with USD ($) equivalent | |||
< 500 ($90) | 44/100 (44.0) | 91/151 (60.3) | 88/165 (53.3) |
500–999 ($91–182) | 29/100 (29.0) | 24/151 (15.9) | 39/165 (23.6) |
1000–2499 ($182–454) | 24/100 (24.0) | 27/151 (17.9) | 32/165 (19.4) |
> 2500 (> $454) | 3/100 (3.0) | 9/151 (6.0) | 6/165 (3.6) |
Laboratory information | |||
Platelet, mean (SD) | 224.9 (150) | 141.3 (104) | 221.1 (59) |
Prothrombin time INR, mean (SD) | 1.3 (0.7) | 1.8 (1.3) | – |
Albumin (g/L), mean (SD) | 35.1 (11.9) | 30.8 (9.9) | 42.0 (7.0) |
APRI score, median (IQR) | 1.5 (0.7–2.9) | 1.4 (0.7–3.0) | 0.3 (0.3–0.5) |
AFP (ng/mL), median (IQR) | 528.1 (31.45–3149) | 4.6 (2.6–8.7) | – |
HBV DNA (IU/mL), median (IQR) | 21,615 (8580–122,500) | 1903.5 (20–76,399) | 3503 (489–15,300) |